Purchase Order 75N93025P00131

Award Date 11/27/24
Potential Completion Date 2/28/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, MA 01887, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. for sterility testing of final containers and biological products. The contract has a ceiling value of $18,300.00 and a completion date of August 5, 2025. Charles River Laboratories is a global contract research organization that provides specialized research products and services to government agencies. This...
This is a $14,155.30 firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency, to Charles River Laboratories, Inc. The contract is not set aside. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract covers the period from July 3, 2025 to July 2, 2026....
This is a $10,359 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Charles River Laboratories, Inc. The contract is not set aside for any small business programs. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. Under this contract, Charles River will provide a range of...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $5,147.10 and runs through November 11, 2015. There is no set-aside designation for this award. Charles River Laboratories is a global contract research organization that provides...
This is a firm fixed-price delivery order contract awarded to Charles River Laboratories, Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the provision of clinical trial materials for virus vaccines. The contract has a ceiling value of $374,769.10 and a period of performance ending on December 31, 2026. No set-aside designation was used for this award. Charles River Laboratories is a global contract research...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. to manufacture and safety test experimental virus vaccines. The contract has a ceiling value of $4,657.50 and a completion date of November 2, 2012. It is not a set-aside contract. Charles River Laboratories is a global contract research organization that provides specialized...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Charles River Laboratories, Inc. The contract has a ceiling value of $4,287.60 and does not have a set-aside designation. Charles River Laboratories, a global contract research organization, is providing research-related products and services to support NIH's biomedical research and public health initiatives. This includes...
This is a firm-fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Charles River Laboratories, Inc. The contract has a ceiling value of $105,000.00 and is for the provision of research models, services, and specialty products to support the agency's research programs. Charles River Laboratories is an established provider of essential products and services for drug discovery, early-stage development, and...
This is a federal contract award to Charles River Laboratories, Inc., a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), has a ceiling value of $4,411.80 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation. Under this contract, Charles River...
This is a $8,232 firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Charles River Laboratories, Inc. (Charles River) on February 27, 2019. The contract has an ultimate completion date of February 26, 2025 and does not utilize a set-aside designation. Charles River is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Charles River Laboratories, Inc. for the CHARLES RIVER LABORATORIES ENDOSAFE NEXGEN MCS PACKAGE AND MATERIALS. The contract has a ceiling value of $21,111.70 and a performance period ending on February 28, 2025. Charles River Laboratories is a global contract research organization that provides essential products and services to support pharmaceutical, biotechnology, and government research and development efforts. The company has been awarded numerous prime and subcontracts by federal agencies to provide specialized research products and services, including laboratory animals, diagnostic testing, virus vaccines, and cell banks. This contract does not have a set-aside designation.

Generated 11/30/24, 9:25 AM